Healthcare - Biotechnology - NASDAQ - US
$ 0.6202
3.37 %
$ 3.13 M
Market Cap
-0.17
P/E
BALANCE SHEET
12.2 M
ASSETS
6.51 M
LIABILITIES
5.66 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Quoin Pharmaceuticals, Ltd.
| Current Assets | 11.3 M |
| Cash & Short-Term Investments | 10.7 M |
| Receivables | 0 |
| Other Current Assets | 591 K |
| Non-Current Assets | 883 K |
| Long-Term Investments | 0 |
| PP&E | 0 |
| Other Non-Current Assets | 883 K |
| Current Liabilities | 3.58 M |
| Accounts Payable | 527 K |
| Short-Term Debt | 0 |
| Other Current Liabilities | 3.05 M |
| Non-Current Liabilities | 2.92 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 2.92 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 2.4 | 2.9 | 7.5 | 0.3 | 5.2 | 4.8 | 4.0 | 1.6 | 1.0 |
| Short Term Investments | 8.3 | 10.0 | 0 | 0 | 0 | 0 | 4.0 | 6.4 | 2.0 |
| Receivables | 0 | 0 | 0 | 0 | 77.3 K | 57.8 K | 70.6 K | 0.2 | 48.1 K |
| Inventory | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| Other Current Assets | 0.6 | 0.5 | 0.7 | 0.1 | 58.5 K | 0.2 | 0.2 | 0.2 | 57.8 K |
| Total Current Assets | 11.3 | 13.4 | 8.5 | 0.5 | 5.4 | 5.0 | 8.2 | 8.4 | 3.1 |
| PP&E | 0 | 0 | 0 | 1.9 | 0.7 | 0.4 | 0.4 | 0.4 | 0.3 |
| Intangible Assets | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.1 | 36.4 K | 5.14 K |
| Other Long Term Assets | 0.3 | 0.4 | 50 K | (1.9) | 1.02 K | 0 | 1 | 0 | 1 |
| Other Assets | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| Total Assets | 12.2 | 14.5 | 9.4 | 1.4 | 6.2 | 5.5 | 8.7 | 8.8 | 3.4 |
| LIABILITIES | |||||||||
| Accounts Payable | 0.5 | 0.6 | 0.9 | 0 | 45.7 K | 0.2 | 0.5 | 0.3 | 0.1 |
| Short Term Debt | 0 | 0 | 743.8 | 1.2 | 0.1 | 0 | 0 | 15.1 K | 0 |
| Other Current Liabilities | 3.0 | 2.8 | (740.4) | 6.6 | 0.9 | 1.1 | 0.7 | 0.5 | 0.6 |
| Total Current Liabilities | 3.6 | 3.5 | 8.7 | 8.0 | 1.1 | 1.3 | 1.2 | 0.9 | 0.7 |
| Long Term Debt | 0 | 0 | 4.1 | 0 | 0.2 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 2.9 | 3.5 | 7 028.6 | 0 | 0.6 | 0.5 | 2.1 | 0.5 | 0 |
| Total Liabilities | 6.5 | 7.1 | 8.7 | 8.0 | 1.9 | 1.8 | 3.3 | 1.4 | 0.7 |
| EQUITY | |||||||||
| Common Stock | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 |
| Retained Earnings | (46.2) | (37.5) | (28.1) | (6.6) | (29.2) | (22.5) | (18.4) | (9.3) | (5.2) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 5.1 | 4.8 | 3.3 | 2.7 | 1.6 | 1.0 |
| Total Equity | 5.7 | 7.4 | 0.7 | (6.6) | 4.3 | 3.7 | 5.4 | 7.4 | 2.7 |
| Total Liabilities and Equity | 12.2 | 14.5 | 9.4 | 1.4 | 6.2 | 5.5 | 8.7 | 8.8 | 3.4 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 0.9 | 0.4 | 26.4 K | 20 K | 3.54 K | 2.16 K | 1.87 K | 1.52 K | 1.24 K |